Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Curevac, explained in plain language.
This study aimed to test a new mRNA treatment (CVHNLC) plus the immunotherapy drug pembrolizumab in people with advanced squamous non-small-cell lung cancer. The goal was to find a safe dose and see if adding chemotherapy later could help. However, the trial was withdrawn before …
Phase: PHASE1 • Sponsor: CureVac • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC